Seek Returns logo

HOLX vs. WAT: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at HOLX and WAT, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolHOLXWAT
Company NameHologic, Inc.Waters Corporation
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesLife Sciences Tools & Services
Market Capitalization14.93 billion USD17.79 billion USD
ExchangeNasdaqGSNYSE
Listing DateMarch 1, 1990November 17, 1995
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of HOLX and WAT by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

HOLX vs. WAT: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolHOLXWAT
5-Day Price Return-1.02%0.41%
13-Week Price Return23.22%-14.21%
26-Week Price Return4.56%-20.91%
52-Week Price Return-16.18%-11.05%
Month-to-Date Return0.46%3.53%
Year-to-Date Return-6.88%-19.42%
10-Day Avg. Volume1.87M0.59M
3-Month Avg. Volume2.81M0.69M
3-Month Volatility34.00%38.80%
Beta0.631.06

Profitability

Return on Equity (TTM)

HOLX

11.51%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

HOLX’s Return on Equity of 11.51% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.

WAT

35.02%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

WAT’s Return on Equity of 35.02% is exceptionally high, placing it well beyond the typical range for the Life Sciences Tools & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

HOLX vs. WAT: A comparison of their Return on Equity (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Net Profit Margin (TTM)

HOLX

13.79%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

A Net Profit Margin of 13.79% places HOLX in the upper quartile for the Health Care Equipment & Supplies industry, signifying strong profitability and more effective cost management than most of its peers.

WAT

21.71%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

A Net Profit Margin of 21.71% places WAT in the upper quartile for the Life Sciences Tools & Services industry, signifying strong profitability and more effective cost management than most of its peers.

HOLX vs. WAT: A comparison of their Net Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Operating Profit Margin (TTM)

HOLX

17.52%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

HOLX’s Operating Profit Margin of 17.52% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.

WAT

27.69%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

An Operating Profit Margin of 27.69% places WAT in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

HOLX vs. WAT: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Profitability at a Glance

SymbolHOLXWAT
Return on Equity (TTM)11.51%35.02%
Return on Assets (TTM)6.32%14.40%
Net Profit Margin (TTM)13.79%21.71%
Operating Profit Margin (TTM)17.52%27.69%
Gross Profit Margin (TTM)56.34%59.02%

Financial Strength

Current Ratio (MRQ)

HOLX

3.55

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

HOLX’s Current Ratio of 3.55 is in the upper quartile for the Health Care Equipment & Supplies industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.

WAT

1.75

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

WAT’s Current Ratio of 1.75 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

HOLX vs. WAT: A comparison of their Current Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

HOLX

0.52

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

HOLX’s Debt-to-Equity Ratio of 0.52 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

WAT

0.67

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

WAT’s Debt-to-Equity Ratio of 0.67 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

HOLX vs. WAT: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Interest Coverage Ratio (TTM)

HOLX

58.29

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

HOLX’s Interest Coverage Ratio of 58.29 is in the upper quartile for the Health Care Equipment & Supplies industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

WAT

11.29

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

WAT’s Interest Coverage Ratio of 11.29 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

HOLX vs. WAT: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Financial Strength at a Glance

SymbolHOLXWAT
Current Ratio (MRQ)3.551.75
Quick Ratio (MRQ)2.591.22
Debt-to-Equity Ratio (MRQ)0.520.67
Interest Coverage Ratio (TTM)58.2911.29

Growth

Revenue Growth

HOLX vs. WAT: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

HOLX vs. WAT: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

HOLX

0.00%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

HOLX currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

WAT

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

WAT currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

HOLX vs. WAT: A comparison of their Dividend Yield (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend Payout Ratio (TTM)

HOLX

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

HOLX has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

WAT

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

WAT has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

HOLX vs. WAT: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Dividend at a Glance

SymbolHOLXWAT
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

HOLX

27.11

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

HOLX’s P/E Ratio of 27.11 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

WAT

26.76

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

In the lower quartile for the Life Sciences Tools & Services industry, WAT’s P/E Ratio of 26.76 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

HOLX vs. WAT: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

HOLX

3.74

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

HOLX’s P/S Ratio of 3.74 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

WAT

5.81

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

WAT’s P/S Ratio of 5.81 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

HOLX vs. WAT: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

HOLX

3.00

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

HOLX’s P/B Ratio of 3.00 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

WAT

9.62

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

At 9.62, WAT’s P/B Ratio is at an extreme premium to the Life Sciences Tools & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

HOLX vs. WAT: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Equipment & Supplies and Life Sciences Tools & Services industry benchmarks.

Valuation at a Glance

SymbolHOLXWAT
Price-to-Earnings Ratio (TTM)27.1126.76
Price-to-Sales Ratio (TTM)3.745.81
Price-to-Book Ratio (MRQ)3.009.62
Price-to-Free Cash Flow Ratio (TTM)16.4828.57